CASMED to Report Second-Quarter 2017 Financial Results and Hold Conference Call on August 8

BRANFORD, Conn., Aug. 01, 2017 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. CASM (CASMED), a leader in non-invasive cerebral oximetry technology, announces that it will report financial results for the second quarter of 2017 on Tuesday, August 8, 2017, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.

Conference call dial-in information is as follows:

  • U.S. callers: (866) 239-5859

  • International callers: (702) 495-1913

Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: www.casmed.com.

A telephone replay will be available from 1:00 p.m. Eastern time on August 8, 2017, through 11:59 p.m. Eastern time on August 22, 2017. Replay dial-in information is as follows:

  • U.S. callers: (855) 859-2056 

  • International callers: (404) 537-3406
  • Conference ID number (U.S. and international): 62473199

  • The replay will also be available at www.casmed.com.

About CASMED® – Monitoring What's Vital

CASMED FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. For further information regarding CASMED, visit the Company's website at www.casmed.com.

Company Contacts

CAS Medical Systems, Inc.

Jeffery A. Baird

Chief Financial Officer

(203) 315-6303

ir@casmed.com

Investors

LHA

Bruce Voss / Jody Cain

(310) 691-7100

bvoss@lhai.com

jcain@lhai.com

@LHA_IR_PR

Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!